Statutory health insurers demand €2.5bn top-up to savings package or face contribution rises

Spending surge

The statutory health insurance system (GKV) reported an unexpectedly high cost increase in the first quarter of 2026. Overall expenditure on medical services rose by 8 percent compared with the same period last year, well above government projections. Hospital treatments were the largest driver (plus 9.4 percent), followed by outpatient doctor visits (7.3 percent) and pharmaceuticals (6.4 percent). GKV chief executive Oliver Blatt described the spending dynamic as "almost unbroken" and said the situation was "unfortunately somewhat worse" than the government had forecast six months ago.

Overall8%

Hospital treatments9.4%

Doctor visits7.3%

Medications6.4%

Overall

8 %

Hospital treatments

9.4 %

Doctor visits

7.3 %

Medications

6.4 %

Data from the article text

Savings gap widens

Health minister Nina Warken (CDU) had originally aimed for annual savings of close to €20 billion, but the cabinet draft now covers only €16.3 billion. The projected funding gap for 2027 has already grown to €18.8 billion, up €3.5 billion from previous estimates. Blatt said that without an additional €2.5 billion, and ideally a larger safety buffer, the insurers would on average have to raise contribution rates at the turn of the year.

“We want a larger buffer.”

The overall contribution rate, shared by employees and employers, currently averages 17.7 percent of gross pay, up from 15.7 percent in 2020. The extra contribution component, set by individual insurers, already sits at an average of 3.1 percent, above the government's target of 2.9 percent. Blatt said insurers would be satisfied if contributions could be held at the 3.1 percent level.

Political timeline

The coalition of CDU/CSU and SPD wants to pass the legislation before the summer recess in mid-July. A vote in the Bundestag could come as early as next week. Chancellor Friedrich Merz (CDU) has instructed that the total savings volume must not be reduced any further. However, resistance from the pharmaceutical industry and from within the coalition itself has already softened several planned cuts.

Green party budget expert Paula Piechotta criticised the tight schedule, saying that under the circumstances it was scarcely credible to consider concessions on pharma savings.

“Ramming the reform through parliament next week - at the expense of thoroughness and balance.”

Where the money should come from

The GKV association is calling for two main sources of additional funds: a higher contribution from the federal budget towards the health costs of welfare recipients, and larger rebates from pharmaceutical companies. Blatt made clear that there should be no additional burden on contributors or patients. The insurers also object to a planned cut in federal payments for so-called non-insurance benefits, warning that this would merely shift costs onto contribution payers. "Linke Tasche, rechte Tasche - Bund lässt Beitragszahlende im Regen stehen," the association stated in its briefing materials.

Outlook

Minister Warken has already signalled that the savings target in the bill will be raised to prevent further contribution increases. But with the gap now widening to as much as €22.8 billion under some scenarios, and the coalition under pressure from healthcare lobbies, a solution before the summer recess remains uncertain. If no beefed-up package is agreed, the GKV's 75 million insured members face another round of contribution hikes in January.